JP2014528696A5 - - Google Patents

Download PDF

Info

Publication number
JP2014528696A5
JP2014528696A5 JP2014517736A JP2014517736A JP2014528696A5 JP 2014528696 A5 JP2014528696 A5 JP 2014528696A5 JP 2014517736 A JP2014517736 A JP 2014517736A JP 2014517736 A JP2014517736 A JP 2014517736A JP 2014528696 A5 JP2014528696 A5 JP 2014528696A5
Authority
JP
Japan
Prior art keywords
antibody
peptide
psca
amino acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014517736A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014528696A (ja
Filing date
Publication date
Priority claimed from DE102011118022.6A external-priority patent/DE102011118022B4/de
Application filed filed Critical
Publication of JP2014528696A publication Critical patent/JP2014528696A/ja
Publication of JP2014528696A5 publication Critical patent/JP2014528696A5/ja
Pending legal-status Critical Current

Links

JP2014517736A 2011-06-30 2012-06-29 前立腺特異幹細胞抗原に対する抗体およびその使用 Pending JP2014528696A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102011118022.6 2011-06-30
DE102011118022.6A DE102011118022B4 (de) 2011-06-30 2011-06-30 Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung
PCT/EP2012/062716 WO2013001065A1 (de) 2011-06-30 2012-06-29 Antikörper gegen das prostata-spezifische stammzellantigen und dessen verwendung

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017002983A Division JP6549622B2 (ja) 2011-06-30 2017-01-12 前立腺特異幹細胞抗原に対する抗体およびその使用

Publications (2)

Publication Number Publication Date
JP2014528696A JP2014528696A (ja) 2014-10-30
JP2014528696A5 true JP2014528696A5 (https=) 2015-10-01

Family

ID=46384405

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2014517736A Pending JP2014528696A (ja) 2011-06-30 2012-06-29 前立腺特異幹細胞抗原に対する抗体およびその使用
JP2017002983A Expired - Fee Related JP6549622B2 (ja) 2011-06-30 2017-01-12 前立腺特異幹細胞抗原に対する抗体およびその使用
JP2019117977A Active JP6886491B2 (ja) 2011-06-30 2019-06-26 前立腺特異幹細胞抗原に対する抗体およびその使用
JP2021081553A Active JP7341185B2 (ja) 2011-06-30 2021-05-13 前立腺特異幹細胞抗原に対する抗体およびその使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2017002983A Expired - Fee Related JP6549622B2 (ja) 2011-06-30 2017-01-12 前立腺特異幹細胞抗原に対する抗体およびその使用
JP2019117977A Active JP6886491B2 (ja) 2011-06-30 2019-06-26 前立腺特異幹細胞抗原に対する抗体およびその使用
JP2021081553A Active JP7341185B2 (ja) 2011-06-30 2021-05-13 前立腺特異幹細胞抗原に対する抗体およびその使用

Country Status (18)

Country Link
US (1) US9200078B2 (https=)
EP (2) EP3505536B1 (https=)
JP (4) JP2014528696A (https=)
AU (1) AU2012277784B2 (https=)
CY (1) CY1121249T1 (https=)
DE (1) DE102011118022B4 (https=)
DK (1) DK2726507T3 (https=)
ES (2) ES2711978T3 (https=)
HR (1) HRP20190289T1 (https=)
HU (1) HUE042008T2 (https=)
LT (1) LT2726507T (https=)
PL (1) PL2726507T3 (https=)
PT (1) PT2726507T (https=)
RS (1) RS58448B1 (https=)
SI (1) SI2726507T1 (https=)
SM (1) SMT201900085T1 (https=)
TR (1) TR201901991T4 (https=)
WO (1) WO2013001065A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011118022B4 (de) * 2011-06-30 2018-01-18 Gemoab Monoclonals Gmbh Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung
EP2990416B1 (en) 2014-08-29 2018-06-20 GEMoaB Monoclonals GmbH Universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders
AU2018219887B2 (en) 2017-02-08 2024-08-15 Dragonfly Therapeutics, LLC Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer
CN110944661A (zh) 2017-02-20 2020-03-31 蜻蜓疗法股份有限公司 结合her2、nkg2d和cd16的蛋白质
WO2019066093A1 (ko) * 2017-09-26 2019-04-04 주식회사 와이바이오로직스 Scf 특이적 항체
CA3237846A1 (en) 2018-02-08 2019-08-15 Dragonfly Therapeutics, Inc. Antibody variable domains targeting the nkg2d receptor
BR112020015994A2 (pt) 2018-02-08 2020-12-15 Dragonfly Therapeutics, Inc. Terapia de combinação do câncer que envolve proteínas de ligação multiespecíficas que ativam células natural killer
WO2019164930A1 (en) 2018-02-20 2019-08-29 Dragonfly Therapeutics, Inc. Multi-specific binding proteins that bind cd33, nkg2d, and cd16, and methods of use
EA202091888A1 (ru) 2018-08-08 2020-10-23 Драгонфлай Терапьютикс, Инк. Вариабельные домены антител, нацеленные на рецептор nkg2d
KR102835308B1 (ko) 2018-08-08 2025-07-21 드래곤플라이 쎄라퓨틱스, 인크. Nkg2d, cd16 및 종양 관련 항원에 결합하는 단백질
EP3833392A4 (en) 2018-08-08 2022-05-18 Dragonfly Therapeutics, Inc. MULTISPECIFIC BINDING PROTEINS FOR BINDING CD33, NKG2D AND CD16 AND METHODS OF USE
JP7512394B2 (ja) 2020-05-06 2024-07-08 ドラゴンフライ セラピューティクス, インコーポレイテッド Nkg2d、cd16及びclec12aに結合するタンパク質
US20230181772A1 (en) * 2020-05-19 2023-06-15 City Of Hope Engineered anti-prostate stem cell antigen fusion proteins and uses thereof
EP4301774A4 (en) 2021-03-03 2025-08-13 Dragonfly Therapeutics Inc METHODS OF TREATING CANCER USING MULTI-SPECIFIC BINDING PROTEINS THAT BIND TO NKG2D, CD16, AND A TUMOR-ASSOCIATED ANTIGEN
WO2024233662A2 (en) * 2023-05-09 2024-11-14 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Molecules that bind to psca polypeptides
US20250302763A1 (en) 2024-02-22 2025-10-02 Capstan Therapeutics, Inc. Immune engineering amplification

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6541212B2 (en) * 1997-03-10 2003-04-01 The Regents Of The University Of California Methods for detecting prostate stem cell antigen protein
EP0981541B1 (en) * 1997-03-10 2004-06-02 The Regents Of The University Of California Psca: prostate stem cell antigen
ES2309012T3 (es) * 1999-10-29 2008-12-16 Genentech, Inc. Composiciones del anticuerpo anti-psca y a sus procedimientos contra celulas cancerigenas que expresen psca.
MXPA06004035A (es) * 2003-10-16 2006-08-31 Micromet Ag Aglutinantes cd3 de-inmunizados multi-especificos.
NZ551627A (en) * 2004-05-28 2010-02-26 Agensys Inc Antibodies and related molecules that bind to PSCA proteins
WO2009032949A2 (en) 2007-09-04 2009-03-12 The Regents Of The University Of California High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection
EP2370467B1 (en) * 2008-10-01 2016-09-07 Amgen Research (Munich) GmbH Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxc d3, igf-1rxcd3 or fapalpha xcd3 bispecific single chain antibody
US20110142811A1 (en) * 2009-12-16 2011-06-16 Deutsches Krebsforschungszentrum Measles virus for the elimination of unwanted cell populations
DE102011118022B4 (de) 2011-06-30 2018-01-18 Gemoab Monoclonals Gmbh Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung

Similar Documents

Publication Publication Date Title
JP2014528696A5 (https=)
JP2016519932A5 (https=)
AR111361A1 (es) Anticuerpos biespecíficos de unión específica a pd1 y lag3
US8618247B2 (en) Peptide, use of the peptide, method for the production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support
RU2015152077A (ru) Тримерные антигенсвязывающие молекулы
JP2019519227A5 (https=)
JPWO2016186206A1 (ja) IgG結合ペプチドによる抗体の特異的修飾
CN102892885B (zh) IgA结合性肽以及利用其的IgA的纯化
EA201490262A1 (ru) Модифицированные белки и пептиды
NZ701444A (en) Antibodies to matrix metalloproteinase 9
JP2016531924A5 (https=)
JP2016508143A5 (https=)
Okochi et al. Array-based rational design of short peptide probe-derived from an anti-TNT monoclonal antibody
Mehaffey et al. Mapping a conformational epitope of hemagglutinin A using native mass spectrometry and ultraviolet photodissociation
WO2014144911A3 (en) Hybrid immunoglobulin containing non-peptidyl linkage
Xiao et al. Nanobody in a Double “Y”-Shaped Assembly: A Promising Candidate for Lateral Flow Immunoassays
JP2023504620A5 (https=)
EA201100741A1 (ru) Антитела к модифицированным пептидам ифр-1/е человека
JP6103772B2 (ja) IgA結合性ペプチド及びそれによるIgAの精製
JP2009278927A (ja) T細胞受容体を模倣する抗体断片及びその製造方法
Hortigüela et al. Engineering recombinant antibodies for polymer biofunctionalization
JP2016002009A (ja) タグ付抗体
KR101300187B1 (ko) 융합 단백질 및 이를 포함하는 바이오센서
JP6245688B2 (ja) IgY特異的結合ペプチド及びそれによるIgYの精製法
JP2019083825A (ja) タグ付抗体